3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
10
Recurrence
4
Neurofibrosarcoma
2
Myeloproliferative Disorders
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Acute
2
Endometrial Neoplasms
2
Wilms Tumor
1
Vascular Neoplasms
1
Uterine Neoplasms
1
Uterine Diseases
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdoid Tumor
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Neoplasms by Site
1
Neoplasms
1
Myoepithelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell
1
Lymphoma
1
Liposarcoma, Myxoid
1
Interventions
Biopsy
9
Specimen Handling
8
Magnetic Resonance Spectroscopy
6
duvelisib
5
Cyclophosphamide
5
ruxolitinib
4
Vincristine
4
10-propargyl-10-deazaaminopterin
4
pembrolizumab
3
X-Rays
3
Prednisone
3
Etoposide
3
Doxorubicin
3
tazemetostat
2
sodium-iodide symporter
2
cemiplimab
2
belinostat
2
Photons
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Immunoglobulin G
2
Disulfides
2
Cytarabine
2
Bortezomib
2
Azacitidine
2
venetoclax
1
talimogene laherparepvec
1
romidepsin
1
prednylidene
1
pegylated granulocyte colony-stimulating factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
selinexor
×
90 days
×
Clear all
No trials found.